In the fall of 2021, the AMA released CPT changes to take effect January 1, 2022.
The breakdown is as follows:
Two new CPT subsections were added:
These new procedure codes will improve the coding and reporting of telemedicine services provided to patients who choose to continue meeting with their providers electronically to manage their care instead of seeing the provider face to face. Evaluation and management time coding guidelines were revised to include specific instructions and guidance, which states that time should not be counted when spent on:
There were no changes to modifiers for 2022!
Here is the link to the AMA codes for the Covid-19 Vaccine:
https://www.ama-assn.org/system/files/covid-19-immunizations-appendix-q-table.pdf
This table links the individual severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine product codes (91300, 91301, 91302, 91303, 91304, 91305, 91306, 91307, 91308) to their associated immunization administration codes (0004A, 0001A, 0002A, 0003A, 0011A, 0012A, 0013A, 0021A, 0022A, 0031A, 0034A, 0041A, 0042A, 0051A, 0052A, 0053A, 0054A, 0064A, 0071A, 0072A, 0073A, 0081A, 0082A), manufacturer name, vaccine name(s), 10 and 11-digit National Drug Code (NDC) Labeler Product ID, and interval between doses. These codes are also located in the Medicine section of the CPT code set.
Additional introductory and instructional information for codes 0001A, 0002A, 0003A, 004A, 0011A, 0012A, 0013A, 0021A, 0022A, 0031A, 0034A, 0041A, 0042A, 0051A, 0052A, 0053A, 0054A, 0064A, 0071A, 0072A, 0073A, 0081A, 0082A, 91300, 91301, 91302, 91303, 91304, 91305, 91306, 91307, and 91308 can be found in the Immunization Administration for Vaccines/Toxoids and Vaccines, Toxoids guidelines in the Medicine section of the CPT code set.
ReferenceJournal of AHIMA 12/20/2021